MEDISCA INC. – Trademark Portfolio
Entity Type: 03
MEDISCA INC. has 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include CAPSUBLEND and CHEW-A-TREAT. The portfolio includes 2 registered trademarks. Filings span 5 Nice Classification classes, led by Class 41 (Education & Entertainment) and Class 10 (Medical Apparatus). This trademark owner is based in Plattsburgh, NY.
661 Route 3, Unit C
Plattsburgh, NY 12901
Showing of trademarks Trademarks
Trademark Classifications
MEDISCA INC.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does MEDISCA INC. have?
MEDISCA INC. has 10 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 abandoned, 3 cancelled.
What trademark classes does MEDISCA INC. file in?
MEDISCA INC. files trademarks across 5 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 10 (Medical Apparatus), Class 16 (Paper Goods), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are MEDISCA INC.'s most well-known trademarks?
MEDISCA INC.'s registered trademark portfolio includes well-known marks such as CAPSUBLEND and CHEW-A-TREAT. These are among 2 currently registered trademarks in the portfolio.
What is MEDISCA INC.'s trademark registration success rate?
MEDISCA INC. has a 20% trademark registration rate, with 2 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.